BioXcel Therapeutics, Inc. (BTAI)

CIK 1720893 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for BioXcel Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 1, 20268-K0001104659-26-104106
Aug 28, 20268-K0001104659-26-102570
Aug 25, 20268-K0001104659-26-100532
Aug 24, 20268-K0001104659-26-099900
Aug 14, 202630001104659-26-097387
Aug 14, 202640001104659-26-097388
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003557
Aug 13, 202610-Q0001104659-26-095965
Aug 11, 20268-K0001104659-26-093710
Aug 3, 20268-K0001104659-26-089436
Jul 6, 20268-K0001104659-26-080501
Jun 17, 202640001104659-26-075300
Jun 17, 202640001104659-26-075302
Jun 17, 202640001104659-26-075298
Jun 17, 202640001104659-26-075301
May 22, 202640001104659-26-065838
May 22, 202640001104659-26-065839
May 22, 202640001104659-26-065841
May 22, 202640001104659-26-065836
May 20, 20261440001964306-26-000254
May 20, 20261440001964306-26-000252
May 20, 20261440001964306-26-000255
May 20, 20261440001964306-26-000253
May 15, 2026SCHEDULE 13G0001172661-26-002135
May 15, 202610-Q0001104659-26-061769